This is a news story, published by MSN, that relates primarily to Bhatt news.
For more Bhatt news, you can click here:
more Bhatt newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
available hypertension drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest hypertension program news, hypertension news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
blood pressure drugsNBC News
•Health
Health
90% Informative
A new type of medication may help lower blood pressure in people with uncontrolled hypertension.
Lorundrostat, part of a class called aldosterone synthase inhibitors, works by blocking the adrenal glands’ synthesis of a hormone.
Uncontrolled hypertension is linked to a higher risk of heart attacks, strokes, heart failure and kidney failure.
Patients in the trial who got lorundrostat were more likely than those who got the placebo to develop high potassium levels. That’s something patients’ doctors would need to keep an eye out for, Bhatt said, because it can lead to abnormal heart rhythms. Cingolani , of Johns Hopkins , said he would like to see long-term studies on the new medication and also ones that could compare lorundrostat to an older medication that works by blocking the receptor for aldosterone. This article was originally published on NBCNews.com .
VR Score
94
Informative language
94
Neutral language
75
Article tone
formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
11
Source diversity
5
Affiliate links
no affiliate links
Small business owner?
